Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
Afimkibart Phase 2 Results Expected
Target Indication
Rheumatoid Arthritis
Clinical Trial
Last updated: 1/2/2026
ROCHE
Roche Holding AG
Pain; Bone Neoplasms; Neoplasm Metastasis
Duchenne Muscular Dystrophy
Lymphocytic Leukemia, Chronic
Anemia
Hepatitis C, Chronic